William L. Risser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
William L. Risser has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jan M. H. Risser
University of Texas School of Public Health
3 shared publications A.T. Bortot
University of Texas—Houston Health Sciences Center Medical School, Department of Pediatrics and Joint Primary Care Fellowship (Dr. Bortot), Houston, Texas, USA
1 shared publicationAmanda L. Risser
Department of Family Medicine, Oregon Health and Science University School of Medicine, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA
1 shared publicationJ M Risser
University of Texas School of Public Health, Houston, TX, USA
1 shared publicationJ.M. Feldmann
1 shared publicationJ.M. Risser
1 shared publication
Latest Publications
- 1 July 2012
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 23 (7) , 457-458
Pelvic inflammatory disease in adolescents between the time of testing and treatment and after treatment for gonorrhoeal and chlamydial infection
In incarcerated adolescents, 13% developed pelvic inflammatory disease (PID) between the time of testing and treatment for chlamydial and gonorrhoeal infection, and 13% developed PID in the 30 days following single-dose treatment for one or both of these infections.
- 1 July 2012
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 23 (7) , 457-458
Pelvic inflammatory disease in adolescents between the time of testing and treatment and after treatment for gonorrhoeal and chlamydial infection
In incarcerated adolescents, 13% developed pelvic inflammatory disease (PID) between the time of testing and treatment for chlamydial and gonorrhoeal infection, and 13% developed PID in the 30 days following single-dose treatment for one or both of these infections.
- 11 January 2012
- Published by Springer Nature
- p. 405-416
Sexually Transmitted Infections in Juvenile Offenders
- 11 January 2012
- Published by Springer Nature
- p. 405-416
Sexually Transmitted Infections in Juvenile Offenders
- 31 December 2008
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 22 (4) , 581-599
Epidemiology of Infections in Women
- 31 December 2008
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 22 (4) , 581-599
Epidemiology of Infections in Women
- 1 June 2007
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 20 (3) , 179-180
Incidence of Fitz-Hugh–Curtis Syndrome in Adolescents Who Have Pelvic Inflammatory Disease
- 1 June 2007
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 20 (3) , 179-180
Incidence of Fitz-Hugh–Curtis Syndrome in Adolescents Who Have Pelvic Inflammatory Disease
- 1 February 2004
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 17 (1) , 39-44
Impact of new diagnostic criteria on the prevalence and incidence of pelvic inflammatory disease
- 1 February 2004
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 17 (1) , 39-44
Impact of new diagnostic criteria on the prevalence and incidence of pelvic inflammatory disease
- 1 February 2002
- Vol. 98 (2) , 36-40
Pelvic inflammatory disease in adolescents: a review.
Pelvic inflammatory disease is relatively common in sexually active adolescents. Most cases are only mildly symptomatic, and criteria for diagnosis should not be stringent. Although chlamydial or gonorrheal infections or both are common in pelvic inflammatory disease, other aerobic and anaerobic organisms are often also present and may be the only causative agents. Commonly used initial therapy, e.g., ceftriaxone and doxycycline, treats some but not all of these organisms. Patients should be seen within 48 to 72 hours after initiating therapy; lack of improvement suggests noncompliance with antibiotic therapy, the need for broader-spectrum antibiotic coverage, a tubo-ovarian abscess, or a mistake in diagnosis. Important preventive measures include screening of sexually active, asymptomatic adolescents for gonorrheal and chlamydial infections, not only in clinics for sexually transmitted diseases and family planning but also in primary care settings. Urine tests that amplify chlamydial and gonococcal nucleic acid are noninvasive and very accurate.
- 1 February 2002
- Vol. 98 (2) , 36-40
Pelvic inflammatory disease in adolescents: a review.
Pelvic inflammatory disease is relatively common in sexually active adolescents. Most cases are only mildly symptomatic, and criteria for diagnosis should not be stringent. Although chlamydial or gonorrheal infections or both are common in pelvic inflammatory disease, other aerobic and anaerobic organisms are often also present and may be the only causative agents. Commonly used initial therapy, e.g., ceftriaxone and doxycycline, treats some but not all of these organisms. Patients should be seen within 48 to 72 hours after initiating therapy; lack of improvement suggests noncompliance with antibiotic therapy, the need for broader-spectrum antibiotic coverage, a tubo-ovarian abscess, or a mistake in diagnosis. Important preventive measures include screening of sexually active, asymptomatic adolescents for gonorrheal and chlamydial infections, not only in clinics for sexually transmitted diseases and family planning but also in primary care settings. Urine tests that amplify chlamydial and gonococcal nucleic acid are noninvasive and very accurate.